Data as of Dec 19
| -0.05 / -3.09%|
The 7 analysts offering 12-month price forecasts for Galena Biopharma Inc have a median target of 6.00, with a high estimate of 8.00 and a low estimate of 2.00. The median estimate represents a +282.17% increase from the last price of 1.57.
The current consensus among 8 polled investment analysts is to Buy stock in Galena Biopharma Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.